Role of XLalphas as a novel alpha-subunit of Gs in hormone signaling

XLalphas 作为 Gs 的新型 α 亚基在激素信号传导中的作用

基本信息

  • 批准号:
    8003287
  • 负责人:
  • 金额:
    $ 3.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-02-01 至 2010-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): XLocs and Gsa, the alpha subunit of the stimulatory G protein (Gsa), are two related proteins derived from the same gene locus, GNAS. XLas differs from the alpha subunit of the stimulatory G protein (Gsa) by a large N-terminal domain with unique sequence. It is otherwise identical to the latter and comprises most of the domains shown to be functionally important for Gsa. Thus, XLas is predicted to act as a novel alpha subunit of the stimulatory G protein. However, owing to its unique N-terminal domain, XLas could importantly differ from Gsa with respect to its biological roles and regulation. When introduced into cells endogenously lacking Gsa and XLas (Gnas^"'" cells), XLas can mediate receptor-stimulated cAMP generation, but receptor coupling to XLas could not be demonstrated in several other cell lines and tissues, suggesting that the actions of XLas can be cell-specific. The animal models in which XLas is ablated have established that XLas is essential for many biological processes, including postnatal adaptation to feeding, energy and glucose metabolism, and adipocyte biology. However, these in vivo studies were unable to demonstrate a role for XLas as a signaling protein that is similar to Gsa. Thus, the biological roles of XLas currently remain unclear. Our main objective is to determine the role of XLas as a novel alpha subunit that can replace Gsa in vivo. In Specific Aim 1, we propose to address whether XLas can substitute for Gsa in vivo by studying the actions of parathyroid hormone in the renal proximal tubule as an in vivo setting whereby the roles of XLos and Gsa can be studied precisely. In Specific Aim 2, we propose to determine whether XLas is involved in the temporal development of PTH-resistance as seen in patients with pseudohypoparathyroidism, a disorder caused by mutations disrupting Gsa activity and/or expression. For accomplishing our aims, we will investigate proximal tubular PTH responsiveness in various transgenic and knockout mouse strains generated by us or by our collaborators. These studies will reveal the interacting roles of XLas and Gsa in the proximal tubular PTH actions and are predicted to improve the understanding of hormone responses that typically involve G protein-coupled receptors. Ultimately, given the importance of this signaling pathway in normal physiology and human disease, our investigations may lead to the identification of novel targets for development of new drugs and diagnostic tools.
描述(由申请人提供):xlos和Gsa(刺激G蛋白(Gsa)的α亚基)是来自同一基因位点GNAS的两个相关蛋白。XLas与刺激G蛋白(Gsa)的α亚基的区别在于具有独特序列的大n端结构域。它在其他方面与后者相同,并且包含对Gsa具有重要功能的大多数域。因此,XLas被预测为刺激G蛋白的一个新的α亚基。然而,由于其独特的n端结构域,XLas在生物学作用和调控方面可能与Gsa有很大的不同。当引入内源性缺乏Gsa和XLas的细胞(Gnas^“'”细胞)时,XLas可以介导受体刺激的cAMP生成,但在其他几种细胞系和组织中无法证明受体与XLas的偶联,这表明XLas的作用可能是细胞特异性的。切除XLas的动物模型已经证实,XLas在许多生物过程中都是必不可少的,包括出生后对喂养的适应、能量和葡萄糖代谢以及脂肪细胞生物学。然而,这些体内研究无法证明XLas作为信号蛋白的作用类似于Gsa。因此,XLas的生物学作用目前尚不清楚。我们的主要目的是确定XLas作为一种新的α亚基在体内可以取代Gsa的作用。在Specific Aim 1中,我们提出通过研究甲状旁腺激素在肾近端小管中的作用,在体内精确研究XLos和Gsa的作用,来研究XLas是否可以在体内替代Gsa。在Specific Aim 2中,我们建议确定XLas是否参与假性甲状旁腺功能低下患者pth耐药的时间发展,假性甲状旁腺功能低下是一种由破坏Gsa活性和/或表达的突变引起的疾病。为了实现我们的目标,我们将研究由我们或我们的合作者产生的各种转基因和敲除小鼠株近端管状甲状旁腺激素的反应性。这些研究将揭示XLas和Gsa在近端管状甲状旁腺激素作用中的相互作用,并有望提高对通常涉及G蛋白偶联受体的激素反应的理解。最终,考虑到这一信号通路在正常生理和人类疾病中的重要性,我们的研究可能会导致新药物和诊断工具开发的新靶点的确定。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MURAT BASTEPE其他文献

MURAT BASTEPE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MURAT BASTEPE', 18)}}的其他基金

Skeletal FGF23 production mediated by GPCR/Gq/PKC signaling
GPCR/Gq/PKC 信号传导介导的骨骼 FGF23 产生
  • 批准号:
    10376665
  • 财政年份:
    2020
  • 资助金额:
    $ 3.96万
  • 项目类别:
Skeletal FGF23 production mediated by GPCR/Gq/PKC signaling
GPCR/Gq/PKC 信号传导介导的骨骼 FGF23 产生
  • 批准号:
    10365935
  • 财政年份:
    2020
  • 资助金额:
    $ 3.96万
  • 项目类别:
Skeletal FGF23 production mediated by GPCR/Gq/PKC signaling
GPCR/Gq/PKC 信号传导介导的骨骼 FGF23 产生
  • 批准号:
    10598571
  • 财政年份:
    2020
  • 资助金额:
    $ 3.96万
  • 项目类别:
XLas Relative to Gsa in Bone and Mineral Ion Metabolism
XLas 在骨和矿物质离子代谢中相对于 Gsa
  • 批准号:
    8675845
  • 财政年份:
    2007
  • 资助金额:
    $ 3.96万
  • 项目类别:
XLas Relative to Gsa in Bone and Mineral Ion Metabolism
XLas 在骨和矿物质离子代谢中相对于 Gsa
  • 批准号:
    8852595
  • 财政年份:
    2007
  • 资助金额:
    $ 3.96万
  • 项目类别:
Role of XLalphas as a novel alpha-subunit of Gs in hormone signaling
XLalphas 作为 Gs 的新型 α 亚基在激素信号传导中的作用
  • 批准号:
    7475183
  • 财政年份:
    2007
  • 资助金额:
    $ 3.96万
  • 项目类别:
Role of XLalphas as a novel alpha-subunit of Gs in hormone signaling
XLalphas 作为 Gs 的新型 α 亚基在激素信号传导中的作用
  • 批准号:
    7777465
  • 财政年份:
    2007
  • 资助金额:
    $ 3.96万
  • 项目类别:
XLas Relative to Gsa in Bone and Mineral Ion Metabolism
XLas 在骨和矿物质离子代谢中相对于 Gsa
  • 批准号:
    8549199
  • 财政年份:
    2007
  • 资助金额:
    $ 3.96万
  • 项目类别:
Role of XLalphas as a novel alpha-subunit of Gs in hormone signaling
XLalphas 作为 Gs 的新型 α 亚基在激素信号传导中的作用
  • 批准号:
    7667806
  • 财政年份:
    2007
  • 资助金额:
    $ 3.96万
  • 项目类别:
XLas Relative to Gsa in Bone and Mineral Ion Metabolism
XLas 在骨和矿物质离子代谢中相对于 Gsa
  • 批准号:
    8438984
  • 财政年份:
    2007
  • 资助金额:
    $ 3.96万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 3.96万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.96万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 3.96万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.96万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 3.96万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.96万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 3.96万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 3.96万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 3.96万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.96万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了